{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:35:31Z","timestamp":1648787731274},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,10,15]]},"DOI":"10.2169\/internalmedicine.6885-20","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T22:06:41Z","timestamp":1618783601000},"page":"3321-3324","source":"Crossref","is-referenced-by-count":0,"title":["Neuromyelitis Optica Complicated by Ornithine Transcarbamylase Deficiency Treated Safely with Pulse Steroid Therapy"],"prefix":"10.2169","volume":"60","author":[{"given":"Ryuto","family":"Yoshida","sequence":"first","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sunouchi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Imafuku","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kido J, Nakamura K, Mitsubuchi H, et al. Long-term outcome and intervention of urea cycle disorders in Japan. J Inherit Metab Dis 35: 777-785, 2012.","DOI":"10.1007\/s10545-011-9427-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Summar LM, Koelker S, Freedenberg D, et al. The incidence of urea cycle disorder. Mol Genet Metab 110: 179-180, 2013.","DOI":"10.1016\/j.ymgme.2013.07.008"},{"key":"3","unstructured":"3. Lofberg E, Gutierrez A, Wernarman J, et al. Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle. Eur J Clin Invest 4: 732-740, 2015."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Atiq M, Holt FA, Safdar K, et al. Adult onset urea cycle disorder in a patient with presumed hepatic encephalopathy. J Clin Gastroenteriol 42: 213-214, 2008.","DOI":"10.1097\/01.mcg.0000225628.84168.25"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lipskind S, Loanzon S, Simi E, Ouyang DW. Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids. J Perinatol 31: 682-684, 2011.","DOI":"10.1038\/jp.2011.23"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gascon-Bayarri J, Campdelacreu J, Estela J, Rene R. Severe hyperammonemia in late-onset ornithine transcarbamylase deficiency triggered by steroid administration. Case Rep Neurol Med 2015: 453752, 2015.","DOI":"10.1155\/2015\/453752"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Summar LM, Barr F, Dawling S, et al. Unmasked adult-onset urea cycle disorder in the critical care setting. Crit Care Clin 21: S1-S8, 2005.","DOI":"10.1016\/j.ccc.2005.05.002"},{"key":"8","unstructured":"8. Hata A, Setoyama C, Shimada K, et al. Ornithine transcarbamylase deficiency resulting from a C-to-T substitution in exon 5 of the ornithine transcarbamylase gene. Am J Hum Genet 45: 123-127, 1989."},{"key":"9","unstructured":"9. Ogino W, Takeshima Y, Nishiyama A, et al. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation. Kobe J Med Sci 53: 229-240, 2007."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. H\u00e4berle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis 42: 1192-1130, 2019.","DOI":"10.1002\/jimd.12100"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kira J, Yamasaki R, Yoshimura S, et al. Efficacy of methylprednisolone pulse therapy for acute phase in Japanese patients with multiple sclerosis and neuromyelitis optica: a multicenter retrospective analysis-1. Whole group analysis. Clin Exp Neuroimmunol 4: 305-317, 2013.","DOI":"10.1111\/cen3.12071"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Schaefer F, Straube E, Oh J, et al. Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant 14: 910-918, 1999.","DOI":"10.1093\/ndt\/14.4.910"},{"key":"13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1352458506071174","volume":"13","author":"S Watanabe","year":"2007","unstructured":"13. Watanabe S, Nakashima I, Misu T, et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Multiple Sclerosis 13: 128-132, 2007.","journal-title":"Multiple Sclerosis","ISSN":"http:\/\/id.crossref.org\/issn\/1352-4585","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Pittock SJ, Fujihara K, Kim HJ, et al. Eculizmab in aquaporin-4-positive neuromyelitis optica spectrum disorder. N Engl J Med 381: 614-625, 2019.","DOI":"10.1056\/NEJMoa1900866"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Traboulsee A, Greenberg BM, Bennett JL, et al. Safety and efficacy of Satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomized, double-blind, multicenter, placebo-controlled phase 3 trial. Lancet Neurol. 19: 402-412, 2020.","DOI":"10.1016\/S1474-4422(20)30078-8"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Caldovic L, Abdikarim I, Narain S, et al. Genotype-phenotype correlations in ornithine transcarbamylase deficiency: a mutation update. J Genet Genomics 24: 181-194, 2015.","DOI":"10.1016\/j.jgg.2015.04.003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rama Rao VK, Chen M, Simard MJ, Norenberg DM. Increased aquaporin-4 expression in ammonia-treated cultured astrocytes. Neuro Rep 14: 2379-2382, 2003.","DOI":"10.1097\/00001756-200312190-00018"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Skowronska M, Albrecht J. Alterations of blood brain barrier function in hyperammonemia: an overview. Neurotox Res 21: 236-244, 2012.","DOI":"10.1007\/s12640-011-9269-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/20\/60_6885-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T05:45:29Z","timestamp":1634363129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/20\/60_6885-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":18,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6885-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"article-number":"6885-20"}}